Literature DB >> 22124933

Clinical use of telemonitoring in chronic heart failure: keeping up with the times or misuse of time?

Nik Stoyanov1, Vince Paul.   

Abstract

Close follow-up of patients with severe heart failure, especially after hospital discharge, has been shown to impact the mortality and readmission rates in this patient population. Monitoring of the patients' physiological status is important for predicting a potential heart failure decompensation. Earlier studies on structured telephone support and telemonitoring suggested a clear benefit on mortality and heart failure admissions, though recent large randomized controlled trials have been neutral. This review looks into the possible reasons for discrepancies in the outcomes. Remote monitoring of implantable cardiac devices is becoming increasingly utilized in a proportion of patients for device follow-up, and recent technology advances have suggested utility of certain device algorithms in detecting heart failure decompensations. Implantable hemodynamic monitors also show promise in this sphere, though have limited evidence at this stage, and further development in the technology is likely before they become part of routine practice.

Entities:  

Mesh:

Year:  2012        PMID: 22124933     DOI: 10.1007/s11897-011-0074-4

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  24 in total

1.  Intrathoracic impedance monitoring to predict decompensated heart failure.

Authors:  Claudia Ypenburg; Jeroen J Bax; Ernst E van der Wall; Martin J Schalij; Lieselot van Erven
Journal:  Am J Cardiol       Date:  2007-01-02       Impact factor: 2.778

2.  Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.

Authors:  Friedrich Koehler; Sebastian Winkler; Michael Schieber; Udo Sechtem; Karl Stangl; Michael Böhm; Herbert Boll; Simone S Kim; Kerstin Koehler; Stephanie Lücke; Marcus Honold; Peter Heinze; Thomas Schweizer; Martin Braecklein; Bridget-Anne Kirwan; Goetz Gelbrich; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2010-12       Impact factor: 15.534

3.  HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association.

Authors:  Bruce L Wilkoff; Angelo Auricchio; Josep Brugada; Martin Cowie; Kenneth A Ellenbogen; Anne M Gillis; David L Hayes; Jonathan G Howlett; Josef Kautzner; Charles J Love; John M Morgan; Silvia G Priori; Dwight W Reynolds; Mark H Schoenfeld; Panos E Vardas
Journal:  Europace       Date:  2008-05-14       Impact factor: 5.214

Review 4.  Structured telephone support or telemonitoring programmes for patients with chronic heart failure.

Authors:  Sally C Inglis; Robyn A Clark; Finlay A McAlister; Jocasta Ball; Christian Lewinter; Damien Cullington; Simon Stewart; John Gf Cleland
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

5.  Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure.

Authors:  G C Fonarow; L W Stevenson; J A Walden; N A Livingston; A E Steimle; M A Hamilton; J Moriguchi; J H Tillisch; M A Woo
Journal:  J Am Coll Cardiol       Date:  1997-09       Impact factor: 24.094

6.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.

Authors:  David J Whellan; Kevin T Ousdigian; Sana M Al-Khatib; Wenji Pu; Shantanu Sarkar; Charles B Porter; Behzad B Pavri; Christopher M O'Connor
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

7.  Randomised trial of telephone intervention in chronic heart failure: DIAL trial.

Authors: 
Journal:  BMJ       Date:  2005-08-20

8.  Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.

Authors:  Cheuk-Man Yu; Li Wang; Elaine Chau; Raymond Hon-Wah Chan; Shun-Ling Kong; Man-Oi Tang; Jill Christensen; Robert W Stadler; Chu-Pak Lau
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

9.  Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction.

Authors:  D L Dries; D V Exner; B J Gersh; M J Domanski; M A Waclawiw; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  1998-09       Impact factor: 24.094

10.  Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF Study (Optimization of Heart Failure Management using OptiVol Fluid Status Monitoring and CareLink).

Authors:  Johannes Brachmann; Michael Böhm; Karin Rybak; Gunnar Klein; Christian Butter; Hanno Klemm; Rolf Schomburg; Johannes Siebermair; Carsten Israel; Anil-Martin Sinha; Helmut Drexler
Journal:  Eur J Heart Fail       Date:  2011-05-08       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.